Sarepta Therapeutics, Inc. (SRPT)
16.01
-0.67
(-4.02%)
USD |
NASDAQ |
Nov 12, 16:00
16.07
+0.06
(+0.37%)
After-Hours: 20:00
Sarepta Therapeutics Market Cap : 1.717B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.717B |
| November 11, 2026 | 1.789B |
| November 10, 2026 | 1.761B |
| November 09, 2026 | 1.849B |
| November 06, 2026 | 1.911B |
| November 05, 2026 | 1.884B |
| November 04, 2026 | 2.036B |
| November 03, 2026 | 1.988B |
| November 02, 2026 | 1.935B |
| October 30, 2026 | 1.967B |
| October 29, 2026 | 2.031B |
| October 28, 2026 | 2.041B |
| October 27, 2026 | 1.995B |
| October 26, 2026 | 1.899B |
| October 23, 2026 | 1.873B |
| October 22, 2026 | 1.920B |
| October 21, 2026 | 1.960B |
| October 20, 2026 | 2.025B |
| October 19, 2026 | 1.873B |
| October 16, 2026 | 1.806B |
| October 15, 2026 | 1.879B |
| October 14, 2026 | 1.778B |
| October 13, 2026 | 1.744B |
| October 12, 2026 | 1.842B |
| October 09, 2026 | 1.885B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.923B |
| October 07, 2026 | 1.848B |
| October 06, 2026 | 1.828B |
| October 05, 2026 | 1.847B |
| October 02, 2026 | 1.848B |
| October 01, 2026 | 1.856B |
| September 30, 2026 | 1.924B |
| September 29, 2026 | 1.969B |
| September 28, 2026 | 1.986B |
| September 25, 2026 | 1.972B |
| September 24, 2026 | 1.942B |
| September 23, 2026 | 2.002B |
| September 22, 2026 | 2.198B |
| September 21, 2026 | 2.127B |
| September 18, 2026 | 2.124B |
| September 17, 2026 | 2.183B |
| September 16, 2026 | 2.087B |
| September 15, 2026 | 2.189B |
| September 14, 2026 | 2.210B |
| September 11, 2026 | 2.160B |
| September 10, 2026 | 2.167B |
| September 09, 2026 | 2.326B |
| September 08, 2026 | 2.212B |
| September 04, 2026 | 2.377B |
| September 03, 2026 | 2.428B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Beam Therapeutics, Inc. | 2.486B |
| Moderna, Inc. | 93.47B |
| Rocket Pharmaceuticals, Inc. | 261.80M |
| Intellia Therapeutics, Inc. | 1.480B |
| Arrowhead Pharmaceuticals, Inc. | 6.655B |
Market Cap Related Metrics
| PS Ratio | 0.8963 |
| Price to Book Value | 1.123 |
| Price to Free Cash Flow | 10.45 |
| Price | 16.01 |
| Earnings Yield | -8.56% |